Bliss GVS Pharma Ltd. (BLISSGVS)
NSE
639.35
-9.30 (-1.43%)
Closed
Sep 3, 2026
Day's Range
635.00665.00
52 wk Range
118.00665.00
Financial Statements - BLISSGVS - Bliss GVS Pharma Ltd.
Revenue
9.20B▲ 14.8%
Net Income
1.34B▲ 49.3%Net Margin 14.6%
EBITDA
2.55B▲ 58.7%
Free Cash Flow
818.86M▲ 176.4%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 9.20B | 8.01B | 7.65B | 7.47B | 7.37B | 5.68B |
| Cost of Goods | 4.25B | 4.13B | 3.82B | 4.01B | 3.90B | 3.29B |
| Gross Profit | 4.95B | 3.88B | 3.83B | 3.46B | 3.46B | 2.38B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.59B | 977.57M | 1.34B | 1B | 1.18B | 909.96M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 1.89B | 1.25B | 1.16B | 1.06B | 541.65M | 1.04B |
| Income Tax | 548.61M | 353.83M | 352.94M | 293.36M | 310.38M | 301.55M |
| Net Income | 1.34B | 902.55M | 815.77M | 767.34M | 231.26M | 739.71M |
| EPS Basic | 12.23 | 8.02 | 7.23 | 6.83 | 1.46 | 6.64 |
| EPS Diluted | 12 | 7.95 | 7.11 | 6.72 | 1.43 | 6.49 |
| Basic Shares Outstanding | 105.61M | 105.11M | 104.31M | 103.80M | 103.33M | 103.14M |
| Diluted Shares Outstanding | 105.61M | 105.11M | 104.31M | 103.80M | 103.33M | 103.14M |
| Ebit | 1.93B | 1.31B | 1.22B | 1.09B | 570.94M | 1.10B |
| Ebitda | 2.55B | 1.60B | 1.87B | 1.29B | 1.64B | 1.28B |
| Net Income Continuous Operations | 1.89B | 1.25B | 1.46B | 1.06B | 1.27B | 1.04B |
| Minority Interests | -55.98M | -59.56M | -61.23M | -58.76M | -80.86M | -54.80M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
